• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Diasend, Abbott ink diabetes data management pact

Diasend, Abbott ink diabetes data management pact

June 9, 2016 By Fink Densford

Diasend, AbbottDiasend said today it inked a cloud-to-cloud deal with Abbott (NYSE:ABT) to connect its LibreLink system to Diasend’s diabetes data management system.

Through the deal, users of Abbott’s FreeStyle Libre flash glucose monitoring systems can integrate data from the device, as well as any other Diasend devices such as insulin pumps, blood glucose monitors or activity trackers, into Diasend’s cloud analytics program.

“At Abbott, we are committed to helping people achieve their best health so we strive to give our customers access to the best possible products and services to help them better manage their diabetes. Our collaboration with Diasend is one more step in that direction and we are excited to bring our customers even closer together with their physicians,” Abbott new product innovation director Eric Davis said in a press release.

The system linking requires a compatible Google (NSDQ:GOOG) Android smartphone device with Abbott’s LibreLink app, the companies said. Glucose levels are read by scanning the sensor with the back of the android phone, and data is automatically populated into the users Diasend account through a cloudbased connection

“We are very excited about the collaboration and the valuable addition that FreeStyle Libre is to our line-up of cloud connections, especially as we note a growing appreciation amongst clinics for passively acquired data. This will make diasend even more functional within both our existing type 1 offering and our upcoming venture into type 2 diabetes,” Diasend CEO Anders Sonesson said in a prepared statement.

In February, Senseonics said it inked a collaborative deal with Diasend to use its diasend Clinic and diasend Personal solutions to analyze data from Senseonics Eversense continuous glucose monitoring system.

Under the agreement, patients and clinicians will be able to use Diasend’s programs to review past Eversense CGM data, as well as insulin pump and activity tracker data, the companies said.

Filed Under: Business/Financial News, Diabetes, Patient Monitoring Tagged With: Diasend

More recent news

  • Neuronetics names Steven Pfanstiel chief financial officer
  • Medtronic to distribute Future Medical’s peripheral guidewires
  • AtriCure completes enrollment in stroke prevention trial
  • GT Medical raises $53M to support brain tumor treatment
  • Imperative Care, Proximie partner to develop surgical robot to treat stroke

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy